BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12658724)

  • 1. Radiolabeling approaches for cholecystokinin B receptor imaging.
    Aloj L; Panico MR; Caracó C; Zannetti A; Del Vecchio S; Di Nuzzo C; Arra C; Morelli G; Tesauro D; De Luca S; Pedone C; Salvatore M
    Biopolymers; 2002; 66(6):370-80. PubMed ID: 12658724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro characterization of CCK8 bearing a histidine-based chelator labeled with 99mTc-tricarbonyl.
    D'Andrea LD; Testa I; Panico M; Di Stasi R; Caracò C; Tarallo L; Arra C; Barbieri A; Romanelli A; Aloj L
    Biopolymers; 2008; 90(5):707-12. PubMed ID: 18615495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo characterization of Indium-111 and Technetium-99m labeled CCK-8 derivatives for CCK-B receptor imaging.
    Aloj L; Panico M; Caraco C; Del Vecchio S; Arra C; Affuso A; Accardo A; Mansi R; Tesauro D; De Luca S; Pedone C; Visentin R; Mazzi U; Morelli G; Salvatore M
    Cancer Biother Radiopharm; 2004 Feb; 19(1):93-8. PubMed ID: 15068617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M; Behr TM
    Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of 111In-DTPAGlu-G-CCK8 for cholecystokinin-B receptor imaging.
    Aloj L; Caracò C; Panico M; Zannetti A; Del Vecchio S; Tesauro D; De Luca S; Arra C; Pedone C; Morelli G; Salvatore M
    J Nucl Med; 2004 Mar; 45(3):485-94. PubMed ID: 15001692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.
    Behr TM; Béhé M; Angerstein C; Gratz S; Mach R; Hagemann L; Jenner N; Stiehler M; Frank-Raue K; Raue F; Becker W
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The [Tc(N)(PNP)]2+ metal fragment labeled cholecystokinin-8 (CCK8) peptide for CCK-2 receptors imaging: in vitro and in vivo studies.
    Agostini S; Bolzati C; Didonè E; Cavazza-Ceccato M; Refosco F; Aloj L; Arra C; Aurilio M; Tornesello AL; Tesauro D; Morelli G
    J Pept Sci; 2007 Apr; 13(4):211-9. PubMed ID: 17269133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrin and cholecystokinin peptide-based radiopharmaceuticals: an in vivo and in vitro comparison.
    Tornesello AL; Aurilio M; Accardo A; Tarallo L; Barbieri A; Arra C; Tesauro D; Morelli G; Aloj L
    J Pept Sci; 2011 May; 17(5):405-12. PubMed ID: 21351319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy.
    de Jong M; Bakker WH; Bernard BF; Valkema R; Kwekkeboom DJ; Reubi JC; Srinivasan A; Schmidt M; Krenning EP
    J Nucl Med; 1999 Dec; 40(12):2081-7. PubMed ID: 10616889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
    von Guggenberg E; Behe M; Behr TM; Saurer M; Seppi T; Decristoforo C
    Bioconjug Chem; 2004; 15(4):864-71. PubMed ID: 15264875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors.
    Laverman P; Béhé M; Oyen WJ; Willems PH; Corstens FH; Behr TM; Boerman OC
    Bioconjug Chem; 2004; 15(3):561-8. PubMed ID: 15149184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformationally constrained CCK8 analogues obtained from a rationally designed peptide library as ligands for cholecystokinin type B receptor.
    De Luca S; Saviano M; Della Moglie R; Digilio G; Bracco C; Aloj L; Tarallo L; Pedone C; Morelli G
    ChemMedChem; 2006 Sep; 1(9):997-1006. PubMed ID: 16915602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCK receptors in human neuroendocrine tumors: clinical implications.
    Reubi JC
    Scand J Clin Lab Invest Suppl; 2001; 234():101-4. PubMed ID: 11713969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor fragment approach to the binding between CCK8 peptide and cholecystokinin receptors: a fluorescence study on type B receptor fragment CCK(B)-R (352-379).
    De Luca S; Sanseverino M; Zocchi I; Pedone C; Morelli G; Ragone R
    Biopolymers; 2005 Mar; 77(4):205-11. PubMed ID: 15666329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence studies on the binding between 1-47 fragment of cholecystokinin receptor CCK(A)-R(1-47) and nonsulfated cholecystokinin octapeptide CCK8.
    Ragone R; De Luca S; Tesauro D; Pedone C; Morelli G
    Biopolymers; 2000-2001; 56(1):47-53. PubMed ID: 11582577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies.
    Behr TM; Béhé MP
    Semin Nucl Med; 2002 Apr; 32(2):97-109. PubMed ID: 11965605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCK-2/gastrin receptor-targeted tumor imaging with (99m)Tc-labeled minigastrin analogs.
    Nock BA; Maina T; Béhé M; Nikolopoulou A; Gotthardt M; Schmitt JS; Behr TM; Mäcke HR
    J Nucl Med; 2005 Oct; 46(10):1727-36. PubMed ID: 16204724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo.
    Reubi JC; Waser B; Schaer JC; Laederach U; Erion J; Srinivasan A; Schmidt MA; Bugaj JE
    Eur J Nucl Med; 1998 May; 25(5):481-90. PubMed ID: 9575243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors.
    Behr TM; Jenner N; Béhé M; Angerstein C; Gratz S; Raue F; Becker W
    J Nucl Med; 1999 Jun; 40(6):1029-44. PubMed ID: 10452322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
    Blommaert AG; Dhôtel H; Ducos B; Durieux C; Goudreau N; Bado A; Garbay C; Roques BP
    J Med Chem; 1997 Feb; 40(5):647-58. PubMed ID: 9057851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.